From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Lipid Management>
  4. Archives

Lipid Management: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 101-125 of 355 are shown

ACCORD: Blood Pressure and Lipid Results

For older diabetic patients, a systolic BP target in the 130s probably is best.

Statins Sharply Lower Cardiovascular Risk Regardless of Baseline LDL Cholesterol

Results of a meta-analysis suggest that guidelines should be reevaluated.

Suicide Risk After Bariatric Surgery?

The long-term risk seems to increase, but psychiatric comorbidities and surgical sequelae may also be factors.

Anacetrapib for Lipid Management: Safety in Numbers

Promising results from an initial trial put cholesteryl ester transfer protein inhibition back on the map.

Abacavir and Cardiovascular Disease — Pieces of the Puzzle?

The underlying reasons for this potential association remain unknown.

You Snooze, You Win

A large, longitudinal cohort study demonstrated a convincing association between short sleep duration and hypercholesterolemia in young women.

I'll Have a Statin with My Burger

Can a single statin dose counteract the cardiovascular risk conferred by an unhealthy meal?

Does Omega-3 Fatty Acid Supplementation Prevent Cardiovascular Events?

In a new study, adding omega-3 fatty acids — from fish, plants, or both — to patients' diets had no significant effect.

Stability of High Cholesterol Levels in Children

Most children with high LDL cholesterol levels had substantially lower levels at the next examination.

Low-Fat or Low-Carb Diet: Does It Make a Difference?

If behavior-modification therapy is part of the weight-loss program, probably not.

Lipid Levels in Young Adults and Subsequent Coronary Calcium

Adverse consequences of dyslipidemia begin early in life.

In Healthy Statin Recipients, Low HDL Might Not Confer Risk After All

HDL cholesterol level was not associated with cardiovascular risk in the JUPITER trial's rosuvastatin group.

How Helpful Is Family History in Identifying Children with Elevated Cholesterol?

Screening on the basis of family history missed many children with hyperlipidemia.

HDL and Cardiovascular Risk in the Presence of Very Low LDL

HDL levels were not associated with residual cardiovascular risk in patients treated with potent statin therapy.

Adherence to Cardiovascular Performance Measures in Outpatients

Adherence to most performance measures was moderate to high.

Statins and Primary Prevention for Patients at High Risk for Heart Disease

The benefit, if any, is very small.

Do Statins Slow Progression of Rheumatic Mitral Stenosis?

Findings from a retrospective study suggest that they do.

Cholesterol Reduction and the Brain–Heart Connection

A post hoc analysis of SPARCL data provides additional support for the benefits of statin therapy after a stroke or transient ischemic attack, in terms of both brain and cardiac protection.

Unintended Effects of Statin Drugs

Kidney failure and cataracts were associated significantly with statin use.

Trends in Acute Myocardial Infarction: More Good News

Evidence is mounting that improvements in prevention and treatment are having favorable effects on incidence and outcomes.

Treating Disease, Not Risk Factors

Observational data suggest that using total carotid arterial plaque burden to guide therapy can improve markers of atherosclerotic disease.

Adding Nuts to Your Diet Lowers Lipids

Cholesterol levels declined with mean daily consumption of 2.4 ounces.

Fibrates and Cardiovascular Prevention

A meta-analysis of randomized trials shows a benefit, but the clinical value of fibrates is still in doubt.

Statin Efficacy in Elders

Rosuvastatin lowered risk for major cardiovascular events.

Immune-Mediated Necrotizing Myopathy Associated with Statins

Unlike toxic myopathies, this condition persists despite statin discontinuation but responds to immunosuppressive therapy.

Items 101-125 of 355 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.